Recently, MIRA, the first microrobot for laparoscopic surgery launched by Virtual Incision Corporation, successfully performed the first operation at the Bryan Medical Center in Lincoln, Nebraska. In this operation, the MIRA surgical platform robot successfully completed the resection of the right colon through a single incision in the navel. The surgery will be part of the MIRA clinical study to support FDA approval of the system.
The MIRA microplatform weighs only 2 pounds (~900g), a nearly 1,000-fold reduction in weight compared to other surgical
Robotic devices currently weighing 2,000 pounds. It is a portable surgical robot that does not require dedicated space or infrastructure, and has full robotic capabilities, capable of performing complex minimally invasive single-incision multi-quadrant abdominal surgeries.
According to the hospital bidding situation disclosed by the government in the past three years, the number of winning bids for endoscopic surgical
Robots is far ahead, followed by orthopedic surgical robots. Endoscopic surgery is a kind of surgery in which a small incision is made in the patient’s waist, the doctor observes the lesion according to the endoscope, and then uses a special lengthening surgical instrument to operate. Endoscope is a medical device commonly used in clinical practice. Medical personnel can use endoscope devices to observe local lesions, obtain tissue materials, and stop bleeding through the natural orifice of the human body or artificially established channels under direct vision or with the support of auxiliary equipment. , resection, drainage, repair or reconstruction of channels, etc., with a wide range of application scenarios.
The data shows that the sales volume of medical endoscopes in my country increased from 17.6 billion yuan in 2016 to 26.3 billion yuan in 2019, with an average annual compound growth rate of 10.9%. The China Business Industry Research Institute predicts that the sales volume of medical endoscopes in my country will reach 26.3 billion yuan in 2021.
Data source: Compiled by China Medical Device Industry Association and China Business Industry Research Institute
The data shows that the sales volume of China’s flexible endoscope
market in 2019 is about 5.34 billion yuan. With the popularization of early gastrointestinal cancer screening and the development of new endoscopic procedures, the domestic flexible endoscope market will continue to maintain its growth in the future. Rapid growth, sales are expected to reach 8.12 billion yuan by 2025.
Data source: Compiled by China Medical Device Industry Association and China Business Industry Research Institute
my country has a huge population base and a large number of patients. The shortage of medical resources has always been a problem to be solved. The expensive and huge surgical equipment is currently distributed in a few tertiary hospitals in big cities. Small and economical portable devices may alleviate the contradiction of uneven distribution of medical resources, and MIRA is such a product. Virtual Incision also mentioned in an interview that the Chinese market will be one of the markets they value in the future. Looking forward to seeing MIRA’s landing in China in the near future.
